Issue: 2012 April 2
Dengue virus turns on mosquito genes that make them hungrier
April 2, 2012
Researchers at the Johns Hopkins Bloomberg School of Public Health have, for the first time, shown that infection with dengue virus turns on mosquito genes that make them hungrier and better feeders, and therefore possibly more likely to spread the disease to humans. Specifically, they found that dengue virus infection of the mosquito’s salivary gland […]
Genetic risk, stressful infancy join to increase schizophrenia risk
April 2, 2012
Working with genetically engineered mice and the genomes of thousands of people with schizophrenia, researchers at Johns Hopkins say they now better understand how both nature and nurture can affect one’s risks for schizophrenia and abnormal brain development in general. The researchers reported in the March 2 issue of Cell that defects in schizophrenia-risk genes […]
Scientists reprogram cancer cells with low doses of epigenetic drugs
April 2, 2012
Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) and decitabine (DAC), are epigenetic-targeted drugs and work to correct cancer-causing alterations that modify DNA. The researchers said that the drugs also […]
Hospitals with no cardiac surgery can perform nonemergency angioplasty
April 2, 2012
Patients who have nonemergency angioplasty to open blocked heart vessels have no greater risk of death or complications when they have the procedure at hospitals without cardiac surgery backup. That is the conclusion of a national study to assess the safety and effectiveness of such procedures at community hospitals. Results of the study, called the […]
Report: Brain cancer blood vessels not substantially tumor-derived
April 2, 2012
Johns Hopkins scientists have published laboratory data refuting studies that suggest blood vessels that form within brain cancers are largely made up of cancer cells. The theory of cancer-based blood vessels calls into question the use and value of anti-cancer drugs that target these blood vessels, including bevacizumab (Avastin). “We don’t question whether brain cancer […]
Commencement: Off they go, with hundreds of helping hands
April 2, 2012
John Birney, a senior associate director in the Admissions Office at Homewood, has a unique front-row seat to the start and end of many a Johns Hopkins student’s career. In his role in Admissions, Birney talks to constituent groups (guidance counselors, faculty, staff and others) and oversees the university’s largest recruitment territory, New York and […]
Take a tour, visit houses … Live Near Your Work
April 2, 2012
House hunting? The Office of Work, Life and Engagement has several upcoming events aimed at helping employees purchase a home close to a Johns Hopkins campus in Baltimore. To get a better sense of the Live Near Your Work program areas, a bus tour will be held on Saturday, April 14. Participants will tour homes […]
Evergreen Museum presents Tai Hwa Goh exhibition
April 2, 2012
Tai Hwa Goh, the 10th artist in residence at the university’s Evergreen Museum & Library, has created a three-dimensional, site-specific installation, Lullaby in Evergreen, that’s now on view as part of guided museum tours. “Evergreen’s House Guests artist-in-residence program was created to continue Alice Warder Garrett’s legacy of supporting artists during the first half of […]
Peabody at Homewood concert series kicks off April 10
April 2, 2012
Johns Hopkins’ Homewood Museum announces the 12th edition of its Peabody at Homewood spring concert series, which showcases some of the top young talents from the university’s Peabody Institute. The performances are presented amid the splendid Federal-era architecture and furnishings of Homewood. This season, the concerts will be held at 5 p.m. on five consecutive […]
Cardiologists’ study named a breakthrough of 2011
April 2, 2012
David Kass, a professor of cardiology in the School of Medicine, and his lab have been recognized in the annual Signaling Breakthroughs of 2011, published by the journal Science Signaling, for their groundbreaking 2011 study published in Science Translational Medicine. The Johns Hopkins researchers’ study revealed how a pacemaker therapy for heart failure, known as […]